LITHIUM TARTRATE
UNII 8AEH504FBC

Substance Identification & Data

This profile provides standardized clinical and technical data for Lithium Tartrate, uniquely identified by the FDA Unique Ingredient Identifier (UNII) 8AEH504FBC.

Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 868-17-7 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.

FDA UNII Code
8AEH504FBC
CAS Registry Number
868-17-7
RxNorm Concept ID
N/A

Detailed Substance Profile

Preferred Name
LITHIUM TARTRATE
Official standardized name for this substance within the FDA UNII nomenclature system.
InChIKey
C4H4O6.2Li
International Chemical Identifier digital signature for unique molecular identification.
SMILES String
JCCYXJAEFHYHPP-OLXYHTOASA-L
Line notation for describing the chemical structure and connectivity of atoms.
PubChem CID
Unique identification number in the NCBI database of chemical substances.
Substance Type
chemical
ISO 11238 classification category (e.g., Chemical, Polymer, Protein).
Ingredient Role
[Li+].[O-]C(=O)[C@@H]([C@H](C([O-])=O)O)O.[Li+]

Synonyms and Nomenclature

This section provides a complete list of nomenclature and identifier mappings for Lithium Tartrate. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.

Systematic Nomenclature

DILITHIUM (2R,3S)-2,3-DIHYDROXYBUTANEDIOATE
LITHIUM TARTRATE